Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues (2008)
- Authors:
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF
- Unidade: FCF
- Assunto: MICROBIOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical Chemistry and Laboratory Medicine
- ISSN: 1434-6621
- Volume/Número/Paginação/Ano: v. 46 , n. S1, supl. 1, p. S510 res. T197, 2008
- Conference titles: International Congress of Clinical Chemistry and Laboratory Medicine/IFCC-WorldLab
-
ABNT
LARGURA, Alvaro et al. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 29 mar. 2024. , 2008 -
APA
Largura, A., Sandrini, F., Bellato, G., Andrade, M. P. de, Carvalho, L. G. S., Marassi, A., et al. (2008). Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Largura A, Sandrini F, Bellato G, Andrade MP de, Carvalho LGS, Marassi A, Largura MA, Hirata RDC, Hirata MH. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S510 res. T197.[citado 2024 mar. 29 ] -
Vancouver
Largura A, Sandrini F, Bellato G, Andrade MP de, Carvalho LGS, Marassi A, Largura MA, Hirata RDC, Hirata MH. Development and evaluation of a biosafe automatized system for treatment, recycling and discarding of clinical microbiology residues. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( S1): S510 res. T197.[citado 2024 mar. 29 ] - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas